Canada’s patent ‘utility’ regime on trial: Adrienne Blanchard for the MLI IP newsletter
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
Tag: IP newsletter
Dodged bullet or missed opportunity with CHEO settlement?: Richard Owens for the MLI IP newsletter
While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic’s departure from the ...
Stop the TPP-IP media pile-on: Richard Owens for the MLI IP newsletter
It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard ...
Top News
-
Canada can’t have fast population growth, housing supply constraints, and housing affordability: Steve Lafleur and Josef Filipowicz for Inside Policy
-
When peaceful protests cross the line into criminal conduct: Andrew Roman for Inside Policy
-
Trudeau-Legault immigration meeting shows federation at its cynical worst: Michael Barutciski
-
Richard Fadden on dealing with foreign interference in Canada: Inside Policy
-
Canadian downstream – Refining our hedge: Rory Johnston
